Can Intravenous Antifungal therapy be safely used in the Outpatient Parenteral Antimicrobial Therapy (OPAT) setting?

Nikolas Rae, Claire Kenny, Eavan G. Muldoon (Lead / Corresponding author)

    Research output: Contribution to journalReview article

    1 Citation (Scopus)
    43 Downloads (Pure)

    Abstract

    Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring. Many patients with fungal infections require prolonged therapy due to resistance or intolerance to oral antifungal agents. Despite the widespread use of OPAT by infection specialists, antifungal agents appear infrequently used in this setting. We suggest that with appropriate patient selection, patients with fungal infections could successfully be treated on OPAT. This article is protected by copyright. All rights reserved.

    Original languageEnglish
    Pages (from-to)196-203
    Number of pages8
    JournalMycoses
    Volume62
    Issue number3
    Early online date30 Nov 2018
    DOIs
    Publication statusPublished - Mar 2019

      Fingerprint

    Keywords

    • OPAT
    • antifungal
    • parenteral antifungal therapy
    • invasive candidosis
    • patient safety
    • outpatient parenteral antimicrobial therapy

    Cite this